BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 21606569)

  • 1. Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.
    Alexopoulos P; Richter-Schmidinger T; Horn M; Maus S; Reichel M; Sidiropoulos C; Rhein C; Lewczuk P; Doerfler A; Kornhuber J
    J Alzheimers Dis; 2011; 26(2):207-10. PubMed ID: 21606569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers.
    Mondadori CR; de Quervain DJ; Buchmann A; Mustovic H; Wollmer MA; Schmidt CF; Boesiger P; Hock C; Nitsch RM; Papassotiropoulos A; Henke K
    Cereb Cortex; 2007 Aug; 17(8):1934-47. PubMed ID: 17077159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
    Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
    Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
    Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
    J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.
    Hostage CA; Roy Choudhury K; Doraiswamy PM; Petrella JR;
    PLoS One; 2013; 8(2):e54483. PubMed ID: 23405083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe.
    Westlye ET; Hodneland E; Haász J; Espeseth T; Lundervold A; Lundervold AJ
    Neuroimage; 2012 Oct; 63(1):507-16. PubMed ID: 22796460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E ϵ4 is positively related to spatial performance but unrelated to hippocampal volume in healthy young adults.
    Stening E; Persson J; Eriksson E; Wahlund LO; Zetterberg H; Söderlund H
    Behav Brain Res; 2016 Feb; 299():11-8. PubMed ID: 26581118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease.
    Blesa R; Aguilar M; Casanova JP; Boada M; Martínez S; Alom J; de la Hoz CH; Sancho J; Fernández O; Gil-Neciga E; Massó JF
    Alzheimer Dis Assoc Disord; 2006; 20(4):248-54. PubMed ID: 17132969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
    Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.